Facilitating Access to Approved Medication

Eflapegrastim-XNST Injection
eflapegrastim-xnst injection is a prescription medicine used to decrease the incidence of infection in patients with nonmyeloid malignancies receiving myelosuppressive anti-cancer drugs associated with clinically significant incidence of febrile neutropenia

Get Access To Eflapegrastim-XNST Injection

EFLAPEGRASTIM For Injection available, genuine price cost in India US UK AE SA BR RU CN

Eflapegrastim-XNST Injection

  • API: Idelalisib
  • Packaging: Tablets
  • Strength: 100 mg and 150 mg Tablets

What is Eflapegrastim-XNST Injection used for?

Idelalisib is a kinase inhibitor indicated for the treatment of patients with:

Relapsed chronic lymphocytic leukemia (CLL), in combination with rituximab, in patients for whom rituximab alone would be considered appropriate therapy due to other co-morbidities.

Note: (For Prescribing Information Approved Drugs, see)

  • The Food and Drug Administration (FDA), USA.
  • The European Medicines Agency (EMA).
Disclaimer

All Trademarks and Brands that appear on website belong to their respective owners does not lay and claim on them we only provide Information. We are NOT ONLINE store and We do not sell Narcotics and Sedatives. Olutasidenib Capsules  is a pharmaceutical drug  To access this medicine, a prescription of your treating doctor is necessary.. Following Information meant for Wholesalers, Suppliers, Exporters, Doctors, Comparator Supplies, Hospitals, Generic, Brand, Corporate Sourcing, reseller, and Pharmacies.